Wells Fargo’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.99M Buy
234,720
+108,450
+86% +$2.31M ﹤0.01% 2234
2025
Q1
$2.44M Buy
126,270
+31,005
+33% +$598K ﹤0.01% 2677
2024
Q4
$1.7M Buy
95,265
+41,890
+78% +$748K ﹤0.01% 2918
2024
Q3
$1.17M Buy
53,375
+19,293
+57% +$423K ﹤0.01% 3110
2024
Q2
$266K Sell
34,082
-5,655
-14% -$44.1K ﹤0.01% 3972
2024
Q1
$165K Buy
39,737
+4,636
+13% +$19.2K ﹤0.01% 4227
2023
Q4
$91.6K Buy
35,101
+6,844
+24% +$17.9K ﹤0.01% 4554
2023
Q3
$52.8K Sell
28,257
-25,021
-47% -$46.8K ﹤0.01% 4805
2023
Q2
$134K Buy
53,278
+48,049
+919% +$121K ﹤0.01% 4578
2023
Q1
$9.15K Sell
5,229
-477
-8% -$835 ﹤0.01% 5568
2022
Q4
$24.3K Sell
5,706
-15,394
-73% -$65.4K ﹤0.01% 4868
2022
Q3
$25K Buy
21,100
+200
+1% +$237 ﹤0.01% 4971
2022
Q2
$21K Sell
20,900
-22,686
-52% -$22.8K ﹤0.01% 5140
2022
Q1
$107K Sell
43,586
-40,900
-48% -$100K ﹤0.01% 4975
2021
Q4
$227K Sell
84,486
-92,574
-52% -$249K ﹤0.01% 4839
2021
Q3
$886K Buy
177,060
+123,895
+233% +$620K ﹤0.01% 4087
2021
Q2
$397K Buy
53,165
+1,765
+3% +$13.2K ﹤0.01% 4456
2021
Q1
$302K Buy
51,400
+6,400
+14% +$37.6K ﹤0.01% 4659
2020
Q4
$212K Buy
45,000
+10,000
+29% +$47.1K ﹤0.01% 4928
2020
Q3
$120K Buy
35,000
+5,170
+17% +$17.7K ﹤0.01% 4998
2020
Q2
$89K Buy
29,830
+27,830
+1,392% +$83K ﹤0.01% 5059
2020
Q1
$5K Buy
+2,000
New +$5K ﹤0.01% 5552
2019
Q4
Sell
-2,000
Closed -$4K 6182
2019
Q3
$4K Buy
+2,000
New +$4K ﹤0.01% 5682
2017
Q2
Sell
-1,200
Closed -$16K 5935
2017
Q1
$16K Hold
1,200
﹤0.01% 5388
2016
Q4
$10K Hold
1,200
﹤0.01% 5464
2016
Q3
$11K Sell
1,200
-200
-14% -$1.83K ﹤0.01% 5425
2016
Q2
$11K Sell
1,400
-1,100
-44% -$8.64K ﹤0.01% 5362
2016
Q1
$17K Hold
2,500
﹤0.01% 5329
2015
Q4
$29K Hold
2,500
﹤0.01% 5246
2015
Q3
$26K Buy
+2,500
New +$26K ﹤0.01% 5223